Skip to main content

Advertisement

Log in

Mutation screening of breast cancer susceptibility genes in Chinese high-risk families: the results will develop the genetic testing strategy in China

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Walsh T, King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11(2):103–105

    Article  CAS  PubMed  Google Scholar 

  2. Li WF, Hu Z, Rao NY et al (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110:99–109

    Article  CAS  PubMed  Google Scholar 

  3. Cao AY, Jin W, Shi PC et al (2009) Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population. Breast Cancer Res Treat. doi:10.1007/s10549-009-0349-6

  4. Cao AY, Huang J, Hu Z et al (2009) The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res Treat 114:457–462

    Article  CAS  PubMed  Google Scholar 

  5. Cao AY, Huang J, Hu Z et al (2009) Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res Treat 115:51–55

    Article  CAS  PubMed  Google Scholar 

  6. Song CG, Hu Z, Yuan WT et al (2006) CHEK2 c. 1100delC may not contribute to genetic background of hereditary breast cancer from Shanghai of China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23:443–445

    CAS  PubMed  Google Scholar 

  7. Domchek SM, Weber BL (2006) Clinical management of BRCA1 and BRCA2 mutation carriers. Oncogene 25:5825–5831

    Article  CAS  PubMed  Google Scholar 

  8. American Society of Clinical Oncology (2003) American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21:2397–2406

    Article  Google Scholar 

  9. Wang SM (2007) Concerns on diagnosis and treatment of breast cancer in China. Chin Med J (Engl) 120:1741–1742

    Google Scholar 

  10. Harris M, Winship I, Spriggs M (2007) Controversies and ethical issues in cancer-genetics clinics. Lancet Oncol 6:301–310

    Article  Google Scholar 

Download references

Acknowledgment

This study was supported in part by the grants from the National Basic Research Program of China (2006CB910501), and the National Natural Science Foundation of China (30371580, 30572109).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhi-Ming Shao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cao, AY., Hu, Z. & Shao, ZM. Mutation screening of breast cancer susceptibility genes in Chinese high-risk families: the results will develop the genetic testing strategy in China. Breast Cancer Res Treat 120, 271–272 (2010). https://doi.org/10.1007/s10549-009-0598-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-009-0598-4

Keywords

Navigation